oa SA Pharmaceutical Journal - New drug focus
|Article Title||New drug focus|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||May 2006|
|Pages||29 - 30|
Extracted from text ... 29 SA Pharmaceutical Journal - May 2006 DRUG INFO Tamiflu(r) - Not a substitute for influenza vaccination Approved indication Tamiflu(r) contains oseltamivir and is an antiviral agent indicated for the treatment of influenza in adults and children over the age of 1 year. It is also indicated for the prevention of influenza in adults and adolescents over the age of 13 years. Mode of action Oseltamivir is a pro-drug and a selective inhibitor of influenza virus neuraminidase enzymes. Viral neuraminidase is essential for the release of newly formed virus particles from infected cells and the spread of infectious virus. The ..
Article metrics loading...